Vitreoretinal Surgery Devices Market | USD 2.33 Billion by 2034
The vitreoretinal surgery devices market size was exhibited at USD 1.65 billion in 2024 and is projected to hit around USD 2.33 billion by 2034, growing at a CAGR of 3.5% during the forecast period 2025 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1.71 Billion |
| Market Size by 2034 | USD 2.33 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 3.5% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Product, Surgery Type, Application, End Use, and Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Alcon, Bausch + Lomb, BVI, Carl Zeiss Meditec, Cooper Vision, Designs for Vision, HOYA Surgical Optics, MedOne, OCULUS, Oertli, Peregrine Surgical, STAAR SURGICAL |
Both government and private sector initiatives are playing a crucial role in raising awareness and improving accessibility to treatment, which is accelerating industry growth. Programs aimed at educating the public about retinal disorders and the benefits of early intervention are increasing demand for advanced surgical devices. Additionally, improved healthcare coverage and reimbursement policies in developed nations are reducing financial barriers, encouraging more patients to seek necessary surgical treatments.
The growing adoption of minimally invasive procedures is another driving force, as these techniques offer advantages such as shorter recovery periods, reduced complications, and enhanced patient comfort. This has led to the increased popularity of devices like microincision vitrectomy systems (MIVS), which minimize trauma and improve surgical precision. Innovations in illumination technologies are enhancing visibility, making complex procedures easier to perform. Additionally, advancements in surgical gases, silicone oils, and dyes are improving surgical outcomes and driving product development.
Vitreoretinal surgery devices include specialized instruments, tools, and systems used for diagnosing and treating conditions affecting the vitreous humor and retina.
The market is categorized into vitreoretinal packs, photocoagulation lasers, vitrectomy machines, vitrectomy probes, illumination devices, and others. In 2024, vitreoretinal packs accounted for the largest revenue share at USD 603.5 million.
These pre-assembled, sterilized packs streamline procurement and preparation, enhancing operational efficiency. They also lower costs and mitigate infection risks by including single-use disposable instruments. Additionally, manufacturers offer customizable options to cater to specific surgical requirements, making these packs highly desirable for surgeons.
Vitreoretinal surgeries are classified into posterior and anterior procedures. The posterior vitreoretinal surgery segment is poised for substantial growth, projected to reach approximately USD 1.9 billion by 2034 at a CAGR of 3.5%.
Advancements such as high-speed vitrectomy machines, intraoperative imaging, and small-gauge instruments are key growth drivers. The aging population, which is more prone to conditions like macular holes and epiretinal membranes, is also contributing to the increased demand for posterior segment surgeries.
The market is divided into diabetic retinopathy, retinal detachment, macular degeneration, and other conditions. In 2024, the diabetic retinopathy segment dominated with a valuation of USD 638.7 million.
Rising diabetes prevalence, particularly in regions like Asia-Pacific, Latin America, and Africa, is increasing the demand for surgical interventions. The adoption of minimally invasive techniques, such as small-gauge vitrectomy systems, is making surgeries more efficient and accessible. Awareness campaigns and better healthcare accessibility are also facilitating earlier diagnoses and timely treatments.
The market is segmented into hospitals, ophthalmic clinics, ambulatory surgery centers, and others. Hospitals led the market in 2024, accounting for 48.0% of total revenue.
Hospitals are equipped with state-of-the-art technology, including vitrectomy machines and real-time imaging systems, making them the preferred setting for vitreoretinal surgeries. Their comprehensive infrastructure, skilled specialists, and advanced tools contribute to superior surgical outcomes.
United States:
The U.S. vitreoretinal surgery devices market was valued at USD 659.5 million in 2024 and is projected to grow at a CAGR of 2.7% from 2025 to 2034.
Advancements in intraoperative imaging, including optical coherence tomography (OCT) and real-time retinal imaging, are enhancing precision, thereby driving demand. Increased awareness and improved diagnostic imaging have led to earlier detection and more surgical interventions. Additionally, insurance programs like Medicare are making these procedures more accessible to the elderly.
United Kingdom:
The UK market is expected to witness significant growth.
The rising prevalence of diabetes is increasing the incidence of diabetic retinopathy, necessitating vitreoretinal surgeries. Additionally, conditions such as retinal detachment, often due to trauma or age-related factors, are driving demand for surgical interventions. A growing trend toward robotic-assisted vitreoretinal surgeries is also enhancing surgical precision and efficiency.
China:
China is a dominant player in the Asia-Pacific vitreoretinal surgery devices market.
The country's aging population is contributing to a rising incidence of age-related macular degeneration (AMD), a leading cause of blindness among the elderly. The expansion of China’s private healthcare sector, driven by increased demand for faster and more advanced treatments, is further propelling market growth.
Leading companies are prioritizing innovation, expanding product offerings, and enhancing surgical precision. Investments in minimally invasive solutions, such as small-gauge vitrectomy systems, are aimed at improving patient recovery times and surgical outcomes. Additionally, integration of advanced imaging technologies like OCT is bolstering diagnostic capabilities and surgical accuracy.
Robotic-assisted surgery is another area of exploration, offering improved control and precision. Companies are also focusing on strategic partnerships with hospitals and ophthalmic clinics, as well as expanding into emerging markets to strengthen their market presence.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the vitreoretinal surgery devices market
By Product
By Surgery Type
By Application
By End Use
By Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers